Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity
Public ClinicalTrials.gov record NCT06579092. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIb Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of AZD5004 in Participants Living With Obesity or Overweight With Comorbidity
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase IIb, global, randomized, parallel-group, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of AZD5004 compared with placebo, given once daily as an oral tablet(s) for 36 weeks, in male and female participants at least 18 years of age who are living with obesity (body mass index \[BMI\] ≥ 30 kg/m2), or overweight (BMI ≥ 27 kg/m2) who have at least 1 weight-related comorbidity
Study identification
- NCT ID
- NCT06579092
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 310 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 8, 2024 (Actual)
- Primary completion
- Nov 21, 2025 (Actual)
- Completion
- Nov 21, 2025 (Actual)
- Last update posted
- Dec 18, 2025
2024 – 2025
United States locations
- U.S. sites
- 30
- U.S. states
- 19
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Chandler | Arizona | 85225 | — |
| Research Site | Huntington Park | California | 90255 | — |
| Research Site | La Mesa | California | 91942 | — |
| Research Site | Lincoln | California | 95648 | — |
| Research Site | Walnut Creek | California | 94598 | — |
| Research Site | Hialeah | Florida | 33012 | — |
| Research Site | Orlando | Florida | 32806 | — |
| Research Site | Lombard | Illinois | 60148 | — |
| Research Site | Valparaiso | Indiana | 46383 | — |
| Research Site | West Des Moines | Iowa | 50266 | — |
| Research Site | Roslindale | Massachusetts | 02131 | — |
| Research Site | Farmington Hills | Michigan | 48334 | — |
| Research Site | Chesterfield | Missouri | 63005 | — |
| Research Site | Omaha | Nebraska | 68134 | — |
| Research Site | Vestal | New York | 13850 | — |
| Research Site | Durham | North Carolina | 27701 | — |
| Research Site | Wilmington | North Carolina | 28401 | — |
| Research Site | Fargo | North Dakota | 58104 | — |
| Research Site | Beachwood | Ohio | 44122 | — |
| Research Site | Cincinnati | Ohio | 45219 | — |
| Research Site | North Charleston | South Carolina | 29405 | — |
| Research Site | Spartanburg | South Carolina | 29303 | — |
| Research Site | Knoxville | Tennessee | 37912 | — |
| Research Site | Austin | Texas | 78735 | — |
| Research Site | Dallas | Texas | 75230 | — |
| Research Site | Houston | Texas | 77040 | — |
| Research Site | Woodway | Texas | 76712 | — |
| Research Site | Ogden | Utah | 84405 | — |
| Research Site | Charlottesville | Virginia | 22911 | — |
| Research Site | Manassas | Virginia | 20110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06579092, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 18, 2025 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06579092 live on ClinicalTrials.gov.